SNCA and Parkinson disease: The exosomal cargo from PD patients contained high levels of alpha-synuclein, IL- 1β, and TNF-α, and their administration led to protein aggregation, neurodegeneration, neuroinflammation, and motor dysfunction in the recipient mice [892].